Bleeding diathesis
Bleeding diathesis main page |
|
---|
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Mehrian Jafarizade, M.D [2]
Overview
Classification
Differential Diagnosis
Platelet disorders | Thrombocytopenia | Infection-Induced Thrombocytopenia | |
Drug-Induced Thrombocytopenia | |||
Heparin-Induced Thrombocytopenia | |||
Immune Thrombocytopenic Purpura (ITP) | |||
Inherited Thrombocytopenia | |||
Thrombotic Thrombocytopenic Purpura (TTP) | |||
Hemolytic Uremic Syndrome | |||
Thromobcytosis | Thrombocytosis in response to acute or chronic inflammation has not been associated with an increased thrombotic risk. In fact, patients with markedly elevated platelet counts (>1.5 million), usually seen in the setting of a myeloproliferative disorder, have an increased risk of bleeding. This appears to be due, at least in part, to acquired von Willebrand disease (VWD) due to platelet-VWF adhesion and removal. | ||
Qualitative Disorders of Platelet Function | Inherited Disorders of Platelet Function | ||
Acquired Disorders of Platelet Function | |||
von Willebrand Disease | Type 1 | ||
Type 2 A | |||
Type 2 B | |||
Type 2 M | |||
Type 3 | |||
Vessel wall disorders | Metabolic and Inflammatory Disorders | ||
Inherited Disorders of the Vessel Wall | |||
Coagulation disorders | Fibrinogen | ||
Prothrombin | |||
Factor V | |||
Factor VII | |||
Factor VIII | |||
Factor IX | |||
Factor X | |||
Factor XI | |||
Factor XII | |||
HK | |||
Prekallikrein | |||
Factor XIII | |||
Hemophilia | Type A | ||
Type B | |||
Type C | |||
Rare diseases | Disseminated Intravascular Coagulation | ||
Vitamin K Deficiency | |||
Coagulation Disorders Associated with Liver Failure | |||
Acquired Inhibitors of Coagulation Factors |